Stemell

Stemell is a biotechnology company specializing in the development and commercialization of regenerative medicine products derived from perinatal tissues. The company focuses on harnessing the therapeutic potential of mesenchymal stem cells (MSCs) and their secreted exosomes to address conditions in orthopedics, aesthetics, and wound care. Their product portfolio includes Stemulate, a line of umbilical cord-derived cellular products, and advanced exosome formulations designed for tissue repair and anti-aging applications. Stemell operates a state-of-the-art laboratory to ensure high-quality processing and characterization of their biologic offerings. The company aims to provide clinicians with safe and effective regenerative tools to improve patient outcomes across various medical disciplines.